NPI: 1790868982 · YOUNGSTOWN, OH 44512 · General Acute Care Hospital · NPI assigned 10/23/2006
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (SYSTEM DIRECTOR) |
| NPI Enumeration Date | 10/23/2006 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 100,828 | $3.17M |
| 2019 | 113,512 | $3.45M |
| 2020 | 93,020 | $3.43M |
| 2021 | 101,570 | $3.81M |
| 2022 | 114,373 | $4.04M |
| 2023 | 291,983 | $10.60M |
| 2024 | 221,272 | $8.10M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 48,617 | 44,334 | $5.99M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 38,571 | 27,050 | $4.44M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 33,832 | 32,005 | $3.85M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 26,274 | 22,974 | $3.37M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9,894 | 8,723 | $2.61M |
| 70450 | Computed tomography, head or brain; without contrast material | 9,462 | 8,472 | $2.16M |
| 96361 | Intravenous infusion, hydration; each additional hour | 5,564 | 3,747 | $1.74M |
| G0378 | Hospital observation service, per hour | 9,991 | 4,592 | $886K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,739 | 2,398 | $651K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6,308 | 6,043 | $608K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,059 | 1,145 | $497K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,746 | 1,527 | $457K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,318 | 2,468 | $410K |
| 80053 | Comprehensive metabolic panel | 55,799 | 47,319 | $405K |
| 64483 | 728 | 657 | $382K | |
| 95811 | 461 | 431 | $283K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2,644 | 1,143 | $282K |
| 41899 | Unlisted procedure, dentoalveolar structures | 414 | 316 | $271K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 695 | 559 | $265K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,504 | 1,454 | $256K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 421 | 386 | $248K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 466 | 388 | $229K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,999 | 1,175 | $195K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3,629 | 1,121 | $192K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3,120 | 824 | $182K |
| 80048 | Basic metabolic panel (calcium, ionized) | 20,729 | 17,350 | $174K |
| 83605 | 25,455 | 21,336 | $160K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 939 | 801 | $152K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 5,409 | 4,372 | $142K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,463 | 1,235 | $142K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 6,508 | 5,277 | $130K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 545 | 461 | $121K |
| 76820 | 8,023 | 4,431 | $117K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,227 | 908 | $114K |
| 76818 | 6,470 | 3,417 | $112K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,726 | 628 | $107K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6,745 | 5,970 | $103K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 3,616 | 3,407 | $102K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,320 | 1,120 | $99K |
| 29848 | 82 | 75 | $96K | |
| 59025 | Fetal non-stress test | 562 | 403 | $95K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 3,222 | 3,049 | $93K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 636 | 594 | $93K |
| 84484 | 25,431 | 19,646 | $93K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 5,053 | 4,112 | $91K |
| 70491 | 329 | 247 | $90K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 73,295 | 62,253 | $88K |
| 93975 | 864 | 715 | $82K | |
| 93971 | 1,121 | 1,000 | $77K | |
| 72131 | 910 | 806 | $76K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 484 | 420 | $73K |
| 70496 | 313 | 256 | $70K | |
| 71046 | Radiologic examination, chest; 2 views | 10,400 | 9,523 | $69K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 39,356 | 33,821 | $67K |
| 86900 | 3,165 | 2,552 | $66K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 2,433 | 1,631 | $65K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 247 | 201 | $63K |
| 84443 | Thyroid stimulating hormone (TSH) | 4,205 | 3,667 | $62K |
| 97161 | 1,203 | 1,032 | $62K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 191 | 159 | $61K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 542 | 464 | $60K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 29,366 | 25,729 | $57K |
| 95800 | 203 | 190 | $57K | |
| 93970 | 442 | 395 | $56K | |
| 71045 | Radiologic examination, chest; single view | 13,597 | 12,139 | $55K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,532 | 2,918 | $54K |
| 76770 | 362 | 311 | $50K | |
| 99201 | 835 | 786 | $49K | |
| 76536 | 421 | 398 | $47K | |
| 76821 | 2,215 | 1,203 | $46K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 584 | 332 | $46K |
| 97113 | 569 | 156 | $45K | |
| 71250 | 590 | 519 | $41K | |
| 47563 | 19 | 14 | $39K | |
| 62323 | 138 | 131 | $39K | |
| 76830 | Ultrasound, transvaginal | 776 | 677 | $38K |
| J1756 | Injection, iron sucrose, 1 mg | 1,248 | 476 | $37K |
| 36415 | Collection of venous blood by venipuncture | 29,474 | 23,349 | $36K |
| 94060 | 230 | 215 | $34K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 16,650 | 13,334 | $33K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,819 | 1,608 | $33K |
| 97165 | 662 | 559 | $32K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,222 | 1,915 | $32K |
| 81001 | 36,598 | 32,222 | $31K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 219 | 199 | $30K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 49 | 38 | $28K |
| 86850 | 2,586 | 2,086 | $28K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 122 | 117 | $27K |
| 82728 | 1,796 | 1,566 | $27K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 70 | 52 | $27K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 16 | 13 | $26K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 473 | 404 | $26K |
| 71271 | 159 | 149 | $25K | |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | 377 | 290 | $25K |
| 85027 | 5,828 | 4,671 | $25K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 23,948 | 20,129 | $23K |
| 96415 | 121 | 80 | $23K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 238 | 133 | $21K |
| 84439 | 1,999 | 1,729 | $20K | |
| 80061 | Lipid panel | 1,914 | 1,711 | $20K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8,304 | 7,298 | $20K |
| 83880 | 4,857 | 3,862 | $20K | |
| 82607 | 1,524 | 1,324 | $19K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,241 | 1,924 | $18K |
| 70486 | 408 | 362 | $17K | |
| 83735 | 7,058 | 5,519 | $17K | |
| 72141 | 112 | 102 | $17K | |
| 94729 | 225 | 212 | $16K | |
| 12001 | 105 | 93 | $16K | |
| 83690 | 21,831 | 19,303 | $16K | |
| 94726 | 221 | 208 | $16K | |
| 76801 | 784 | 662 | $15K | |
| 87088 | 6,185 | 5,517 | $15K | |
| 96367 | 393 | 287 | $15K | |
| 64493 | 28 | 28 | $14K | |
| 80320 | 1,024 | 888 | $14K | |
| 74018 | 466 | 388 | $14K | |
| 73030 | 1,028 | 888 | $13K | |
| 96376 | 3,616 | 1,990 | $13K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 306 | 283 | $13K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,151 | 2,669 | $12K |
| 73502 | 643 | 570 | $12K | |
| 93017 | 136 | 109 | $11K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,371 | 1,133 | $11K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 487 | 387 | $11K |
| 73630 | 1,056 | 937 | $11K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 507 | 377 | $11K |
| 86901 | 3,125 | 2,551 | $11K | |
| 84702 | 2,363 | 1,864 | $10K | |
| 83540 | 1,178 | 1,034 | $10K | |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 114 | 114 | $10K |
| 73130 | 849 | 729 | $10K | |
| 90714 | 657 | 563 | $10K | |
| 73700 | 99 | 96 | $10K | |
| 70498 | 270 | 227 | $10K | |
| 86140 | 1,122 | 889 | $9K | |
| 84112 | 179 | 133 | $9K | |
| 86592 | 629 | 531 | $9K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,408 | 1,172 | $9K |
| 82570 | 1,761 | 1,364 | $8K | |
| 81002 | 35,666 | 13,043 | $8K | |
| 84550 | 1,568 | 1,194 | $8K | |
| 73562 | 872 | 795 | $8K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 78 | 63 | $8K |
| 72128 | 250 | 217 | $8K | |
| 86803 | 551 | 453 | $8K | |
| 87040 | 2,695 | 1,172 | $8K | |
| 83550 | 1,120 | 982 | $8K | |
| 85610 | 4,351 | 3,431 | $8K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 320 | 90 | $7K |
| 93226 | 43 | 41 | $7K | |
| 72100 | 544 | 479 | $7K | |
| 82746 | 1,380 | 1,198 | $7K | |
| 82962 | 5,336 | 2,969 | $7K | |
| 80076 | 1,242 | 1,068 | $7K | |
| 86038 | 415 | 309 | $7K | |
| 83970 | 313 | 267 | $7K | |
| 87340 | 499 | 407 | $6K | |
| 73221 | 25 | 17 | $6K | |
| 87081 | 519 | 436 | $6K | |
| 73610 | 798 | 706 | $6K | |
| 36430 | 54 | 37 | $6K | |
| 76813 | 183 | 158 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 435 | 369 | $6K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 44 | 25 | $5K |
| 84156 | 1,479 | 1,098 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 934 | 706 | $5K |
| 72110 | 81 | 71 | $5K | |
| 86376 | 402 | 334 | $5K | |
| 97535 | Self-care/home management training, each 15 minutes | 189 | 126 | $4K |
| 73110 | 535 | 466 | $4K | |
| 86039 | 233 | 179 | $4K | |
| 64721 | 14 | 12 | $4K | |
| 74420 | 37 | 25 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 213 | 197 | $4K |
| 85378 | 1,258 | 1,104 | $4K | |
| 93225 | 43 | 41 | $4K | |
| 73560 | 292 | 238 | $3K | |
| J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu | 55 | 38 | $3K |
| 97014 | 104 | 27 | $3K | |
| 74178 | 18 | 15 | $3K | |
| 86800 | 241 | 197 | $3K | |
| 84134 | 238 | 221 | $3K | |
| 81003 | 5,919 | 5,415 | $3K | |
| 73590 | 363 | 319 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,003 | 901 | $3K |
| 93246 | 37 | 37 | $3K | |
| 84100 | 899 | 614 | $3K | |
| 84481 | 230 | 202 | $3K | |
| 83615 | 677 | 518 | $3K | |
| 87210 | 748 | 632 | $3K | |
| 82731 | 81 | 68 | $3K | |
| 86703 | 95 | 82 | $3K | |
| 85379 | 1,732 | 1,531 | $3K | |
| 84520 | 264 | 232 | $2K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 42 | 13 | $2K |
| 10060 | 15 | 12 | $2K | |
| 84630 | 176 | 163 | $2K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 252 | 204 | $2K |
| 85652 | 844 | 703 | $2K | |
| 85730 | 1,318 | 1,007 | $2K | |
| A9609 | Fludeoxyglucose f18 up to 15 millicuries | 13 | 13 | $2K |
| 76870 | 76 | 67 | $2K | |
| 94664 | 1,135 | 941 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 331 | 323 | $2K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 29 | 17 | $2K |
| 82565 | 308 | 256 | $2K | |
| C1776 | Joint device (implantable) | 232 | 189 | $2K |
| 84425 | 174 | 161 | $2K | |
| 80143 | 1,553 | 1,300 | $2K | |
| 86923 | 60 | 36 | $2K | |
| 84703 | 1,155 | 975 | $2K | |
| 12002 | 14 | 12 | $2K | |
| 82550 | 1,007 | 761 | $2K | |
| J3490 | Unclassified drugs | 98 | 52 | $2K |
| 82784 | 173 | 92 | $2K | |
| 87077 | 978 | 754 | $2K | |
| 86762 | 115 | 99 | $1K | |
| 82248 | 1,287 | 1,088 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,488 | 1,679 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,564 | 2,622 | $1K |
| 85651 | 364 | 253 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,483 | 1,438 | $1K |
| 82043 | 278 | 255 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,064 | 900 | $1K |
| 86787 | 53 | 42 | $1K | |
| 87070 | 814 | 628 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 20,109 | 17,192 | $1K |
| 82805 | 69 | 58 | $1K | |
| 82947 | 455 | 258 | $1K | |
| 73564 | 45 | 42 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,589 | 1,763 | $1K |
| 85014 | 563 | 345 | $1K | |
| 92567 | 33 | 28 | $968.33 | |
| 86308 | 323 | 241 | $936.08 | |
| 64447 | 14 | 13 | $935.43 | |
| 82077 | 632 | 467 | $905.87 | |
| 82525 | 69 | 67 | $901.74 | |
| 80179 | 1,534 | 1,285 | $877.48 | |
| 84145 | 254 | 217 | $870.74 | |
| 80074 | 100 | 82 | $848.89 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,092 | 980 | $824.11 |
| 87634 | 311 | 261 | $815.30 | |
| 82044 | 118 | 101 | $813.95 | |
| 85384 | 270 | 194 | $797.25 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 84 | 37 | $730.77 |
| 00790 | 249 | 185 | $714.38 | |
| 86481 | 13 | 12 | $701.28 | |
| 87205 | 702 | 522 | $700.85 | |
| 86147 | 46 | 12 | $665.48 | |
| 85018 | 559 | 340 | $618.73 | |
| 86317 | 26 | 15 | $590.03 | |
| 86706 | 31 | 28 | $588.27 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 1,433 | 501 | $586.67 |
| 87186 | 404 | 265 | $578.09 | |
| C1889 | Implantable/insertable device, not otherwise classified | 37 | 29 | $568.33 |
| J0690 | Injection, cefazolin sodium, 500 mg | 4,995 | 3,090 | $562.66 |
| 90715 | 27 | 26 | $528.80 | |
| 81025 | 555 | 437 | $520.79 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 19,267 | 15,759 | $506.54 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 933 | 562 | $468.72 |
| 73090 | 78 | 63 | $447.06 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 9,230 | 6,704 | $414.21 |
| 83020 | 41 | 37 | $411.62 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 832 | 668 | $391.16 |
| J2704 | Injection, propofol, 10 mg | 11,730 | 7,618 | $386.70 |
| 01810 | 763 | 682 | $378.34 | |
| 84590 | 51 | 50 | $376.25 | |
| 82533 | 31 | 26 | $369.10 | |
| 73552 | 45 | 43 | $365.49 | |
| 85460 | 33 | 24 | $347.07 | |
| 86431 | 16 | 12 | $338.69 | |
| 84403 | 34 | 28 | $331.90 | |
| 86403 | 160 | 124 | $306.67 | |
| 82010 | 573 | 480 | $303.56 | |
| 82553 | 19 | 16 | $299.64 | |
| 82800 | 491 | 425 | $295.37 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 4,246 | 3,305 | $286.30 |
| 88342 | 304 | 242 | $276.81 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 6,112 | 4,620 | $269.18 |
| 71101 | 14 | 12 | $229.17 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 929 | 732 | $223.63 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 728 | 516 | $213.92 |
| 82140 | 72 | 58 | $212.98 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 18,344 | 16,208 | $200.55 |
| 73521 | 16 | 12 | $200.52 | |
| 83516 | 24 | 15 | $194.25 | |
| 72170 | 30 | 27 | $187.97 | |
| 87449 | 27 | 25 | $174.07 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 626 | 374 | $171.75 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 425 | 312 | $170.92 |
| 80164 | 17 | 13 | $166.70 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,121 | 1,656 | $161.24 |
| J2060 | Injection, lorazepam, 2 mg | 689 | 459 | $153.18 |
| 84146 | 13 | 12 | $142.10 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 761 | 643 | $128.99 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 2,493 | 2,284 | $119.43 |
| 82150 | 55 | 46 | $111.15 | |
| 87075 | 156 | 104 | $104.30 | |
| 85045 | 29 | 24 | $91.71 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 370 | 281 | $71.21 |
| 73080 | 13 | 13 | $65.59 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 141 | 97 | $65.48 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 222 | 123 | $64.21 |
| J7030 | Infusion, normal saline solution , 1000 cc | 830 | 676 | $60.46 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 222 | 158 | $58.23 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 31 | 25 | $57.78 |
| 84436 | 29 | 28 | $48.32 | |
| 00813 | 173 | 143 | $47.60 | |
| J1644 | Injection, heparin sodium, per 1000 units | 104 | 27 | $41.62 |
| J1836 | Injection, metronidazole, 10 mg | 135 | 65 | $39.55 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 5,565 | 4,278 | $36.53 |
| J3480 | Injection, potassium chloride, per 2 meq | 511 | 282 | $35.59 |
| J1953 | Injection, levetiracetam, 10 mg | 16 | 13 | $35.07 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 583 | 287 | $31.55 |
| C1769 | Guide wire | 200 | 151 | $27.40 |
| 88304 | 910 | 686 | $22.01 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 27 | 26 | $20.52 |
| 84132 | 48 | 40 | $19.06 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | 25 | $17.95 |
| 73060 | 15 | 12 | $15.56 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 42 | 38 | $15.28 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 330 | 318 | $11.13 |
| J1940 | Injection, furosemide, up to 20 mg | 169 | 108 | $10.95 |
| J7050 | Infusion, normal saline solution, 250 cc | 416 | 302 | $9.77 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 393 | 353 | $9.29 |
| J1171 | Injection, hydromorphone, 0.1 mg | 185 | 124 | $7.57 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 19 | 12 | $6.36 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 1,004 | 810 | $5.36 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 95 | 82 | $2.35 |
| J1790 | Injection, droperidol, up to 5 mg | 49 | 39 | $2.25 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 361 | 290 | $1.90 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 36 | 25 | $1.76 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 31 | 27 | $0.86 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 52 | 44 | $0.37 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 910 | 875 | $0.25 |
| 00811 | 86 | 65 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 154 | 120 | $0.00 |
| 00731 | 455 | 369 | $0.00 | |
| H1000 | Prenatal care, at-risk assessment | 154 | 137 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 44 | 37 | $0.00 |
| A4565 | Slings | 71 | 61 | $0.00 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | 79 | 76 | $0.00 |
| C1758 | Catheter, ureteral | 25 | 25 | $0.00 |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 31 | 25 | $0.00 |
| 00840 | 67 | 36 | $0.00 | |
| 00812 | 75 | 66 | $0.00 | |
| 00910 | 18 | 12 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 19 | 14 | $0.00 |
| 64484 | 86 | 69 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 101 | 79 | $0.00 |
| J1921 | Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg | 14 | 12 | $0.00 |
| 88311 | 241 | 187 | $0.00 | |
| 96368 | 36 | 25 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 14 | 12 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 13 | 12 | $0.00 |
| 64494 | 28 | 28 | $0.00 | |
| C9399 | Unclassified drugs or biologicals | 107 | 85 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 13 | 12 | $0.00 |
| G0379 | Direct admission of patient for hospital observation care | 52 | 39 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 17 | 13 | $0.00 |
| 87807 | 26 | 26 | $0.00 |